← USPTO Trademark Applications

TRIMODULIN

Cancelled TM79222116 Kind: cancelled Apr 02, 2026

Abstract

Pharmaceutical immunoglobulin preparations for treatment of immunological disorders and bacterial infections, in particular severe community-acquired pneumonia (sCaP)

Filing Date

2017-10-19